OTC Markets OTCPK - Delayed Quote USD

Bayer Aktiengesellschaft (BAYRY)

6.25

-0.02

(-0.32%)

At close: April 23 at 4:00:00 PM EDT

World Bank adds Bayer, Hyatt and other CEOs to private sector initiative

WASHINGTON (Reuters) -The World Bank on Wednesday added four top executives, including Bayer AG CEO Bill Anderson and Hyatt Hotels CEO Mark Hoplamazian, to an initiative working to address barriers to private sector investment in developing countries. World Bank President Ajay Banga, former CEO of Mastercard, launched the Private Sector Investment Lab shortly after taking office in June 2023, assembling 15 business leaders to brainstorm ways to create more jobs in developing countries.

Reuters 19 hours ago

BAYN.DE
ConcertAI and Bayer to boost precision oncology with AI and ML insights

Translational360 is a recently introduced integrated research-grade longitudinal clinical molecular database.

Pharmaceutical Technology yesterday

BAYN.DE
Farmers’ Favorite Weedkiller Nears Its End, Bayer Warns

Pharmaceutical and agriculture conglomerate Bayer said it could stop producing the world’s most popular weedkiller, unless it gets court protection against lawsuits blaming the herbicide for causing cancer. Roundup has generated tens of billions of dollars in sales over time for Bayer and Monsanto, the biotech seed giant and developer of Roundup that Bayer acquired in 2018. Bayer currently produces about 40% of the world’s glyphosate, which farmers spray across fields to tame crop-threatening weeds.

The Wall Street Journal 9 days ago

BAYRY
-0.32%
BAYZF
Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from confirmatory studies.

Zacks 12 days ago

BAYN.DE
FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation

The U.S. Food And Drug Administration (FDA) granted full approval to Bayer AG’s (OTC:BAYRY) Vitrakvi (larotrectinib) for adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion. Vitrakvi has demonstrated clinically meaningful and durable responses across various NTRK fusion-positive solid tumors. FDA first granted Vitrakvi accelerated approval in November 2018. The approval is based on data from three multicenter, open-label, single-arm

Benzinga 13 days ago

BAYN.DE
Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco

The latest investor updates on stocks that are trending on Thursday.

Yahoo Finance UK 14 days ago

STZ

^DJI

TSM
Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Lonza Group Ag (LZAGY) have performed compared to their sector so far this year.

Zacks 14 days ago

BAYN.DE

LZAGY
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

The latest investor updates on stocks that are trending on Wednesday.

Yahoo Finance UK 15 days ago

DAL

GM

SVNDF
Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study

BAYRY subsidiary Vividion Therapeutics doses the first patient in a phase I study on VVD-159642 to treat advanced solid tumors.

Zacks 19 days ago

BAYN.DE
J&J's Third Bankruptcy Attempt to End Talc Suits Rejected

J&J fails in its third attempt to settle tens of thousands of lawsuits claiming its talc-based powder caused cancer.

Zacks 22 days ago

JNJ

BAYN.DE
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma

Bayer obtains an exclusive worldwide license for MTA-cooperative PRMT5 inhibitor from Suzhou Puhe BioPharma for selective targeting of MTAP-deleted tumors.

Zacks 27 days ago

BAYN.DE
Bayer (BAYRY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Bayer (BAYRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks 28 days ago

BAYN.DE
Bayer Down on Verdict to Pay $2.1B to Plaintiff in Roundup Litigation

BAYRY suffers a setback after the jury at the Barnes Roundup trial in the State Court of Cobb County, Georgia, reached a verdict in favor of the plaintiff. Stock declines.

Zacks 29 days ago

BAYN.DE
5 Large Drug Stocks to Watch as Industry Recovers

R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo Nordisk (NVO), Novartis (NVS), Pfizer (PFE) and Bayer (BAYRY) are worth retaining in one's portfolio

Zacks 30 days ago

ABBV

PFE

NVS
-1.15%
Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case

Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged cancer risk tied to its Roundup weed killer.

Investopedia 30 days ago

BAYN.DE
Nvidia, Palantir, Tesla, MicroStrategy, Bayer, James Hardie, AZEK: Stocks to watch today

Stocks extended gains as an economic indicator — the March flash Purchasing Mangers Index (PMI) — improved by more than expected. The S&P 500, the Nasdaq 100, and the Dow Jones Industrial Average had all gained at the open following reports that the Trump administration may take a more-targeted approach than initially planned on tariffs it’s set to roll out on April 2.

Quartz 30 days ago

BAYN.DE

MSTR
Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Enhabit (EHAB) have performed compared to their sector so far this year.

Zacks 30 days ago

BAYN.DE

EHAB
Bayer Shares Plunge After U.S. Court Defeat in Roundup Case

Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court reached a verdict in favor of the plaintiff.

The Wall Street Journal last month

BAYRY
-0.32%
BAYZF
Georgia jury orders Monsanto parent to pay nearly $2.1 billion in Roundup weedkiller lawsuit

A jury in Georgia has ordered Monsanto parent Bayer to pay nearly $2.1 billion in damages to a man who says the company's Roundup weed killer caused his cancer, according to attorneys representing the plaintiff. The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide. The penalties awarded include $65 million in compensatory damages and $2 billion in punitive damages, law firms Arnold & Itkin LLP and Kline & Specter PC said in a statement.

Associated Press Finance last month

BAYN.DE
Is Bayer (BAYRY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks last month

BAYN.DE

Performance Overview

Return	BAYRY	DAX P (^GDAXI)
YTD	+28.07%	+9.98%
1-Year	-14.85%	+21.05%
3-Year	-62.31%	+54.83%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bayer Aktiengesellschaft (BAYRY)

World Bank adds Bayer, Hyatt and other CEOs to private sector initiative

ConcertAI and Bayer to boost precision oncology with AI and ML insights

Farmers’ Favorite Weedkiller Nears Its End, Bayer Warns

Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi

FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation

Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco

Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study

J&J's Third Bankruptcy Attempt to End Talc Suits Rejected

Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma

Bayer (BAYRY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Bayer Down on Verdict to Pay $2.1B to Plaintiff in Roundup Litigation

5 Large Drug Stocks to Watch as Industry Recovers

Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case

Nvidia, Palantir, Tesla, MicroStrategy, Bayer, James Hardie, AZEK: Stocks to watch today

Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?

Bayer Shares Plunge After U.S. Court Defeat in Roundup Case

Georgia jury orders Monsanto parent to pay nearly $2.1 billion in Roundup weedkiller lawsuit

Is Bayer (BAYRY) Stock Undervalued Right Now?

Performance Overview